Fatigue, Endocrinopathies, and Metabolic Disorders

Fatigue is a frequent reason for seeking medical attention. Endocrine dysfunction is a common etiology of fatigue. In fact, thyroid function is usually one of the first explanations on the list of possible diagnoses. The symptoms associated with endocrinopathies are frequently “nonspecific,” and psychiatric disease or psychological disorders need to be differentiated. Often, this can be accomplished using biological measures of hormone function, such as measures of thyroid, pituitary, parathyroid, and adrenal hormone levels. The field of endocrinology is highly dependent on an algorithmic approach to differential diagnosis using hormone levels as the guide. The use of self‐reports helps identify at‐risk patients, and raises suspicions about whether there is an abnormality, but diagnosis is dependent on laboratory values. Metabolic abnormalities, such as hyper‐ or hypoglycemia, dyslipidemia, and gonadal dysfunction can also contribute to fatigue. A better understanding of the interactions among hormones, their releasing factors, and regulation of inflammation will help identify abnormalities early and help distinguish endocrinopathies from other causes of fatigue. Early identification of these abnormalities may reduce end‐organ damage and improve treatment strategies.

[1]  D. Shoback Clinical practice. Hypoparathyroidism. , 2008, The New England journal of medicine.

[2]  E. Fliers,et al.  Polymorphisms in the brain‐specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients , 2008, Clinical endocrinology.

[3]  Evangelia Charmandari,et al.  Endocrinology of the stress response. , 2005, Annual review of physiology.

[4]  S. Marx Hyperparathyroid and hypoparathyroid disorders. , 2000, The New England journal of medicine.

[5]  S. Wessely Chronic Fatigue: Symptom and Syndrome , 2001, Annals of Internal Medicine.

[6]  L. Wartofsky,et al.  Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.

[7]  W. Drake,et al.  Optimizing gh therapy in adults and children. , 2001, Endocrine reviews.

[8]  W. Katon,et al.  Medical Symptoms without Identified Pathology: Relationship to Psychiatric Disorders, Childhood and Adult Trauma, and Personality Traits , 2001, Annals of Internal Medicine.

[9]  G. Chrousos Stress and disorders of the stress system , 2009, Nature Reviews Endocrinology.

[10]  Toft Ad Clinical practice. Subclinical hyperthyroidism. , 2001, The New England journal of medicine.

[11]  D. Cooper Clinical practice. Subclinical hypothyroidism. , 2001, The New England journal of medicine.

[12]  P. Stewart,et al.  Hypopituitarism: clinical features, diagnosis, and management. , 2008, Endocrinology and metabolism clinics of North America.

[13]  A. Toft Clinical practice. Subclinical hyperthyroidism. , 2001, The New England journal of medicine.

[14]  A. Grossman,et al.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. , 1998, Endocrine reviews.

[15]  F. Mantero,et al.  Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. , 2002, Endocrine reviews.

[16]  S. Silverberg,et al.  Clinical practice. Asymptomatic primary hyperparathyroidism. , 2004, The New England journal of medicine.

[17]  H. Burger,et al.  A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire. , 2006, Sexual health.

[18]  L. Nelson Clinical practice. Primary ovarian insufficiency. , 2009, The New England journal of medicine.

[19]  Duanping Liao,et al.  Insomnia with objective short sleep duration is associated with a high risk for hypertension. , 2009, Sleep.

[20]  Health-related Quality of Life in Adults , 2008 .

[21]  N. Takasu [Thyroid hormone and the cardiovascular system]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[22]  C. Tsigos,et al.  Stress, Visceral Obesity, and Metabolic Complications , 2006, Annals of the New York Academy of Sciences.

[23]  S. Ezzat,et al.  The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. , 2006, Endocrine reviews.